Human pathogens, nosocomial infections, heat-sensitive textile implants, and an innovative approach to deal with them.
Implantable polymers, as used for biomedical applications, inherently have to be sterile. Nonetheless, most implants, particularly those comprised of biomaterials developed in recent years for tissue engineering, are heat sensitive. Therefore, use of hazardous (radio)chemicals--due to lack of alternative methods--is still state of the art for sterilization processes. The drawbacks of these techniques, both drastic and well known, lead to the demand for an alternative sterilization method, which is equally obvious and urgent. High-pressure fluid treatment is a low-temperature technique that is already in use for pasteurization of liquid food products. This paper explores inactivation of vegetative microorganisms, spores, and endotoxins adherent to solid surfaces using compressed CO(2). Pressures ranging from 50 to 100 bar and temperatures from 25 °C to 50 °C were explored to investigate liquid, gaseous or supercritical state. Analysis of variance (ANOVA) and statistical modeling were used to identify the optimum parameter settings for inactivation of pathogenic bacteria and fungi (Candida albicans, Staphylococcus aureus). The addition of small amounts of ozone ensures inactivation of persistent spores (Bacillus stearothermophilus, B. subtilis) up to 10(6) cfu/ml, while endotoxins remain in practically unchanged concentration on the polymer surface. We then discuss environmental issues of the process and inactivation mechanisms. The replacement of conventional chemicals with nonpersistent ones resolves organizational and safety-related issues and protects natural resources as well as handling staff. The pressurized-fluid-based method exhibits mild treatment parameters, thus protecting sensitive textures. Finally, an outlook on possible applications of this innovative technique is presented.
Cinquemani
Claudio
C
German Textile Research Centre (DTNW), Institute at the University of Duisburg-Essen, Krefeld, Germany. cinquemani@gmx.de
D000704:Analysis of Variance; D001419:Bacteria / Q000187:drug effects* / Q000254:growth & development; D002245:Carbon Dioxide / Q000494:pharmacology*; D003428:Cross Infection / Q000517:prevention & control; D004731:Endotoxins / Q000302:isolation & purification; D005658:Fungi / Q000187:drug effects* / Q000254:growth & development; D006358:Hot Temperature; D006801:Humans; D015233:Models, Statistical; D010126:Ozone / Q000494:pharmacology*; D011312:Pressure; D013171:Spores, Bacterial / Q000254:growth & development; D013172:Spores, Fungal / Q000254:growth & development; D013242:Sterilization / Q000379:methods*; D013784:Textiles / Q000382:microbiology
D004731:Endotoxins; D002245:Carbon Dioxide; D010126:Ozone
Acta Biomater. 2008 Nov;4(6):1745-51
18676191
Langmuir. 2005 Jan 18;21(2):530-6
15641820
Biomaterials. 2002 Jul;23(14):2855-61
12069325
Arch Biochem Biophys. 1954 Jul;51(1):208-16
13181475
J Biotechnol. 2000 Jan 21;76(2-3):97-119
10656326
Biochim Biophys Acta. 1966 Jan 4;112(1):102-9
5947884
Biotechnol Bioeng. 2005 Jan 5;89(1):32-41
15540198
Environ Res. 1975 Apr;9(2):179-86
1140179
J Microbiol Methods. 2006 Sep;66(3):479-85
16516991
Biochim Biophys Acta. 2002 Mar 25;1595(1-2):250-65
11983400
Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10344-8
10468610
J Bacteriol. 1963 Mar;85:567-76
14174901
Enzyme Microb Technol. 2001 Feb 1;28(2-3):176-182
11166809
Colloids Surf B Biointerfaces. 2005 Jul 25;44(1):15-24
15982857
J Supercrit Fluids. 2007 Oct 1;42(3):366-372
19756235
Meat Sci. 2005 Feb;69(2):225-32
22062812
J Biotechnol. 1995 May 1;39(3):229-37
7766403
J Hosp Infect. 2005 Mar;59(3):205-14
15694977
J Agric Food Chem. 2002 Jan 16;50(2):400-5
11782215
Int J Food Microbiol. 2005 Apr 15;100(1-3):21-32
15854689
Int J Artif Organs. 2005 Nov;28(11):1126-37
16353119
J Biotechnol. 2006 Jun 10;123(4):504-15
16497403